Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_assertion type Assertion NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_head.
- NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_assertion description "[Resistance to camptothecin (CPT), a topoisomerase I (Top1) inhibitor, is frequently encountered in non-small cell lung cancer (NSCLC) and CPT resistance is linked with TDP1, an enzyme capable of cleaving the covalent linkage between stabilized Top1 with DNA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_provenance.
- NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_assertion evidence source_evidence_literature NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_provenance.
- NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_assertion SIO_000772 17118488 NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_provenance.
- NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_assertion wasDerivedFrom befree-20140225 NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_provenance.
- NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_assertion wasGeneratedBy ECO_0000203 NP252534.RAEKi6MzgSLCjjMeKe8Q55ZLzDSfnpvuEEWrm-5ALHPNk130_provenance.